öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ººÎÇìè¤
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º47

ËùÊôԺУ£ºôßÄÏ´óѧ
ËùÊôԺϵ£ºÉúÃü¿Æѧ¼¼ÊõѧԺ
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º


ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºtqyhe@jnu.edu.cn


¸öÈ˼òÊö :
ºÎÇì褲©Ê¿£¬¡°³¤½­Ñ§Õß¡±ÌØƸ½ÌÊÚ¡£1995Äê»ñÓ¢¹úл·Æ¶ûµÂ´óѧ£¨University of Sheffield£©ÉúÎﻯѧ²©Ê¿Ñ§Î»£»ÔøÈÎÓ¢¹úÅ£½ò´óѧ£¨University of Oxford£©·ÃÎÊѧÕߣ¬ÃÀ¹ú·ðÃÉÌØ´óѧ£¨University of Vermont£©¼°Ïã¸Û´óѧÖúÀí½ÌÊÚ(Ñо¿)£»2006Äê»Ø¹úÄÚºó±»¹ú¼ÒÈËʲ¿¡¢¿Æ¼¼²¿µÈÆß²¿Î¯ÆÀΪ¡°ÐÂÊÀ¼Í°ÙǧÍòÈ˲Ź¤³Ì¡±¹ú¼Ò¼¶ÈËÑ¡£»2008ÄêÈëÑ¡¡°³¤½­Ñ§Õß¡±ÌØƸ½ÌÊÚ£»2010Äê»ñ¹úÎñÔºÕþ¸®ÌØÊâ½òÌù£»2011Äê»ñµÃ¹ã¶«Ê¡¡°ÎåÒ»ÀͶ¯½±Õ¡±¡£ ½üÄêÀ´Ò»Ö±ÖÂÁ¦ÓÚÉúÎﻯѧºÍ¹¦Äܵ°°×ÖÊ×éѧÁìÓòµÄÑо¿¹¤×÷£¬ÔÚ×éѧ·½·¨½¨Á¢¡¢¸ÐȾºÍ°©Ö¢Ïà¹Øµ°°×ÖÊ×éѧ¼°¿¹Ö×ÁöÒ©ÎïµÄ×÷ÓûúÀíµÈÁìÓò½øÐÐÁËϵͳµÄ´´ÐÂÐÔÑо¿¡£ÔÚ¹ú¼ÊÆÚ¿¯ÉÏ·¢±íSCIÂÛÎÄ190Óàƪ£¬±»ÒýÓó¬¹ý6000´Î£¨½ØÖÁ2017Äê11Ô£©£¬h-index: 37£»Ïà¹Ø¿ÆÑгɹû»ñµÃÃÀ¹ú¹ú¼Ò°©Ö¢Ñо¿Ôº£¨NCI£©¼°ÃÀ¹úNewsRXµÄרÎÄÆÀ½é¡£³ö°æרÖø¡¶¹¦Äܵ°°×ÖÊÑо¿¡·¼°²Î±à6²¿Öø×÷¡£½üÄêÀ´Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¡¢¹ú¼ÒÖصã»ù´¡Ñо¿·¢Õ¹¼Æ»®¡°973¡±¼°Ïã¸ÛÕþ¸®RGCµÈÏîÄ¿ºÍ¿ÎÌâ10Ïî¡£ÊÇмÓÆÂÎÀÉú²¿¿ÆÑлù½ð£¨NMRC£©¼°ÄϷǹú¼ÒҽѧÑо¿»ù½ð£¨MRC£©µÄÆÀÉóר¼Ò¡£ ÏÖÈÎôßÄÏ´óѧÉúÃü¿Æѧ¼¼ÊõѧԺԺ³¤¼°ôßÄÏ´óѧÉúÃüÓ뽡¿µ¹¤³ÌÑо¿ÔºÔº³¤£¬½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦£»¼æÈλùÒòÒ©Îï¹ú¼Ò¹¤³ÌÑо¿ÖÐÐĸ±Ö÷ÈΡ£ÊÇÃÀ¹úASBMB»áÔ±£¬Ó¢¹ú»Ê¼Ò»¯Ñ§»á»áÊ¿(Fellow, FRSC)£¬Öйúµ°°×ÖÊ×éѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±Ö÷ÈÎίԱºÍµ°°×ÖÊöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áίԱ£¬¹ú¼ÒÖصãÑз¢¼Æ»®ÏîÄ¿Ê×ϯ¿Æѧ¼Ò¡£

¿ÆÑй¤×÷ :
1. Xu WW, Li B, Guan XY, Chung SK, Wang Y, Yip YL, Law SY, Chan KT, Lee NP, Chan KW, Xu LY, Li EM, Tsao SW, He QY, Cheung AL. ¡°Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression.¡± Nat Commun. 2017 Feb 108:14399. doi: 10.1038/ncomms14399.
2. Wang Y, Yu RY, Zhang J, Zhang WX, Huang ZH, Hu HF, Li YL, Li B, He QY. ¡°Inhibition of Nrf2 enhances the anticancer effect of 6-O-angeloylenolin in lung adenocarcinoma.¡± Biochem Pharmacol. 2017 Apr 1129:43-53. doi: 10.1016/j.bcp.2017.01.006.
3. Li B, Xu WW, Han L, Chan KT, Tsao SW, Lee NP, Law S, Xu LY, Li EM, Chan KW, Qin YR, Guan XY, He QY, Cheung AL.¡± MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF.¡± Oncogene. 2017 Mar 13. doi: 10.1038/onc.2017.29.
4. Li B, Xu WW, Lam AKY, Wang Y, Hu HF, Guan XY, Qin YR, Saremi N, Tsao SW, He QY, Cheung ALM. ¡°Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.¡± Oncotarget. 2017 Mar 17. doi: 10.18632/oncotarget.16333.

½ÌÓý±³¾° :
1995: PhD, University of Sheffield, UK£» 1988: MSc, Jinan University / Sun Yat-Sen University, China£» 1985: BSc, Jinan University, China¡£